Use of imiquimod for residual acral melanoma

8Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Recent reports suggest that topical imiquimod cream is an effective treatment option for certain types of melanomas. No reports exist on the efficacy of using imiquimod cream to treat melanoma located on the plantar surface of the foot. We present two patients with a melanoma of the foot who had residual melanoma following surgical excision with acceptable margins. The patients were then treated with topical imiquimod for 8 weeks after which a repeat biopsy of the affected region showed no evidence of residual melanoma in situ. The use of topical imiquimod cream should be considered in the management of residual melanoma in situ of the plantar surface of the foot. Copyright 2014 BMJ Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Sue, G. R., Hanlon, A., Lazova, R., & Narayan, D. (2014). Use of imiquimod for residual acral melanoma. BMJ Case Reports. https://doi.org/10.1136/bcr-2014-203826

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free